Clinical Experience with Fludarabine in Leukaemia
- 1 January 1994
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 47 (6) , 39-49
- https://doi.org/10.2165/00003495-199400476-00007
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology.1993
- Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent.1993
- Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis.1992
- Treatment of advanced chronic lymphocytic leukemia by fludarabineAnnals of Hematology, 1991
- Fludarabine phosphate therapy in other lymphoid malignancies.1990
- Pharmacokinetics of 2-F-ara-A (9-beta-D-arabinofuranosyl-2-fluoroadenine) in cancer patients during the phase I clinical investigation of fludarabine phosphate.1990
- Immunologic and molecular evaluation of residual disease in b-cell chronic lymphocytic leukemia patients in clinical remission phaseCancer, 1989
- MULTIPLE AGENT CHEMOTHERAPY (POACH) IN PREVIOUSLY TREATED AND UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA1988
- FLUDARABINE PHOSPHATE (NSC 312878) INFUSIONS FOR THE TREATMENT OF ACUTE-LEUKEMIA - PHASE-I AND NEUROPATHOLOGICAL STUDY1986
- Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity.Journal of Clinical Oncology, 1986